Target Price | $148.41 |
Price | $129.47 |
Potential | 14.63% |
Number of Estimates | 39 |
39 Analysts have issued a price target Pinduoduo 2026 . The average Pinduoduo target price is $148.41. This is 14.63% higher than the current stock price. The highest price target is $184.80 42.74% , the lowest is $118.17 8.73% . | |
A rating was issued by 45 analysts: 32 Analysts recommend Pinduoduo to buy, 12 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Pinduoduo stock has an average upside potential 2026 of 14.63% . Most analysts recommend the Pinduoduo stock at Purchase. |
42 Analysts have issued a sales forecast Pinduoduo 2025 . The average Pinduoduo sales estimate is $60.7b . This is 7.22% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $66.9b 18.18% , the lowest is $55.9b 1.20% .
This results in the following potential growth metrics:
2024 | $55.3b | 59.04% |
---|---|---|
2025 | $60.7b | 9.64% |
2026 | $69.9b | 15.11% |
2027 | $79.1b | 13.26% |
2028 | $78.7b | 0.51% |
2029 | $82.0b | 4.24% |
2030 | $85.5b | 4.28% |
2031 | $87.8b | 2.57% |
2032 | $90.0b | 2.58% |
37 Pinduoduo Analysts have issued a net profit forecast 2025. The average Pinduoduo net profit estimate is $49.2b . This is 253.20% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $60.5b 334.06% , the lowest is $40.7b 191.83% .
This results in the following potential growth metrics and future Net Margins:
2024 | $15.8b | 87.31% |
---|---|---|
2025 | $49.2b | 211.56% |
2026 | $65.2b | 32.44% |
2027 | $78.3b | 20.17% |
2028 | $94.2b | 20.27% |
2029 | $100b | 6.49% |
2030 | $107b | 6.39% |
2031 | $111b | 4.09% |
2032 | $116b | 4.00% |
2024 | 28.55% | 17.78% |
---|---|---|
2025 | 81.13% | 184.18% |
2026 | 93.34% | 15.05% |
2027 | 99.04% | 6.11% |
2028 | 119.72% | 20.88% |
2029 | 122.32% | 2.17% |
2030 | 124.79% | 2.02% |
2031 | 126.63% | 1.47% |
2032 | 128.39% | 1.39% |
37 Analysts have issued a Pinduoduo forecast for earnings per share. The average Pinduoduo EPS is $8.67 . This is 268.94% higher than earnings per share in the financial year 2024. The highest EPS forecast is $10.65 353.19% , the lowest is $7.16 204.68% .
This results in the following potential growth metrics and future valuations:
2024 | $2.67 | 85.42% |
---|---|---|
2025 | $8.67 | 224.72% |
2026 | $11.48 | 32.41% |
2027 | $13.80 | 20.21% |
2028 | $16.59 | 20.22% |
2029 | $17.67 | 6.51% |
2030 | $18.80 | 6.40% |
2031 | $19.57 | 4.10% |
2032 | $20.35 | 3.99% |
Current | 55.09 | 33.98% |
---|---|---|
2025 | 14.93 | 72.90% |
2026 | 11.28 | 24.45% |
2027 | 9.38 | 16.84% |
2028 | 7.80 | 16.84% |
2029 | 7.33 | 6.03% |
2030 | 6.89 | 6.00% |
2031 | 6.62 | 3.92% |
2032 | 6.36 | 3.93% |
Based on analysts' sales estimates for 2025, the Pinduoduo stock is valued at an EV/Sales of 2.21 and an P/S ratio of 3.04 .
This results in the following potential growth metrics and future valuations:
Current | 2.37 | 20.92% |
---|---|---|
2025 | 2.21 | 6.71% |
2026 | 1.92 | 13.13% |
2027 | 1.70 | 11.70% |
2028 | 1.70 | 0.51% |
2029 | 1.64 | 4.07% |
2030 | 1.57 | 4.10% |
2031 | 1.53 | 2.51% |
2032 | 1.49 | 2.51% |
Current | 3.26 | 17.56% |
---|---|---|
2025 | 3.04 | 6.74% |
2026 | 2.64 | 13.13% |
2027 | 2.33 | 11.70% |
2028 | 2.35 | 0.51% |
2029 | 2.25 | 4.06% |
2030 | 2.16 | 4.11% |
2031 | 2.10 | 2.51% |
2032 | 2.05 | 2.51% |
Analyst | Rating | Action | Date |
---|---|---|---|
New Street Research |
Buy
➜
Neutral
|
Downgrade | Aug 26 2025 |
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | Aug 26 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Aug 26 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Aug 26 2025 |
China Renaissance |
Buy
➜
Hold
|
Downgrade | May 28 2025 |
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | May 28 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | May 28 2025 |
Analyst Rating | Date |
---|---|
Downgrade
New Street Research:
Buy
➜
Neutral
|
Aug 26 2025 |
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
Aug 26 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Aug 26 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Aug 26 2025 |
Downgrade
China Renaissance:
Buy
➜
Hold
|
May 28 2025 |
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
May 28 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
May 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.